Skip to main content

Medications for Ovarian Cancer

Other names: Cancer, Ovarian; Cancer, Ovaries

Ovarian cancer is a malignant neoplasm (abnormal growth) located on the ovaries.

Drugs used to treat Ovarian Cancer

The following list of medications are in some way related to or used in the treatment of this condition.

Filter
Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
carboplatin 9.3 3 reviews for carboplatin to treat Ovarian Cancer
Rx D N
Generic name:
carboplatin systemic
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Avastin 4.8 6 reviews for Avastin to treat Ovarian Cancer
Rx C N
Generic name:
bevacizumab systemic
Drug class:
VEGF/VEGFR inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
paclitaxel 7.5 2 reviews for paclitaxel to treat Ovarian Cancer
Rx D N
Generic name:
paclitaxel systemic
Drug class:
mitotic inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Doxil Rate Add review
Rx D N
Generic name:
doxorubicin liposomal systemic
Drug class:
antibiotics/antineoplastics
For consumers:
dosage, interactions, side effects
Lynparza 7.3 9 reviews for Lynparza to treat Ovarian Cancer
Rx D N
Generic name:
olaparib systemic
Drug class:
PARP inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Zejula 6.4 48 reviews for Zejula to treat Ovarian Cancer
Rx N
Generic name:
niraparib systemic
Drug class:
PARP inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
olaparib 7.4 10 reviews for olaparib to treat Ovarian Cancer
Rx D N
Generic name:
olaparib systemic
Brand name:
Lynparza
Drug class:
PARP inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Gemzar Rate Add review
Rx D N
Generic name:
gemcitabine systemic
Drug class:
antimetabolites
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
doxorubicin liposomal 4.0 1 review for doxorubicin liposomal to treat Ovarian Cancer
Rx D N
Generic name:
doxorubicin liposomal systemic
Brand name:
Doxil
Drug class:
antibiotics/antineoplastics
For consumers:
dosage, interactions, side effects
cisplatin Rate Add review
Rx D N
Generic name:
cisplatin systemic
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
gemcitabine Rate Add review
Rx D N
Generic name:
gemcitabine systemic
Brand names:
Gemzar, Infugem
Drug class:
antimetabolites
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Alkeran Rate Add review
Rx D N
Generic name:
melphalan systemic
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
doxorubicin 0.0 1 review for doxorubicin to treat Ovarian Cancer
Rx D N
Generic name:
doxorubicin systemic
Drug class:
antibiotics/antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
methotrexate Off-label Rate Add review
Rx X N X
Generic name:
methotrexate systemic
Drug class:
antimetabolites, antirheumatics, antipsoriatics, other immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Off-label:
Yes
bevacizumab 4.2 7 reviews for bevacizumab to treat Ovarian Cancer
Rx C N
Generic name:
bevacizumab systemic
Brand names:
Avastin, Alymsys, Mvasi, Zirabev, Avzivi, Vegzelma
Drug class:
VEGF/VEGFR inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
cyclophosphamide 5.0 1 review for cyclophosphamide to treat Ovarian Cancer
Rx D N
Generic name:
cyclophosphamide systemic
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Rubraca Rate Add review
Rx N
Generic name:
rucaparib systemic
Drug class:
PARP inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
melphalan Rate Add review
Rx D N
Generic name:
melphalan systemic
Brand name:
Alkeran
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Hycamtin Rate Add review
Rx D N
Generic name:
topotecan systemic
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
topotecan Rate Add review
Rx D N
Generic name:
topotecan systemic
Brand name:
Hycamtin
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Cosmegen Rate Add review
Rx D N
Generic name:
dactinomycin systemic
Drug class:
antibiotics/antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Toposar Rate Add review
Rx D N
Generic name:
etoposide systemic
Drug class:
mitotic inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Etopophos Rate Add review
Rx D N
Generic name:
etoposide systemic
Drug class:
mitotic inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
niraparib 6.5 52 reviews for niraparib to treat Ovarian Cancer
Rx N
Generic name:
niraparib systemic
Brand name:
Zejula
Drug class:
PARP inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Elahere 8.8 5 reviews for Elahere to treat Ovarian Cancer
Rx N
Generic name:
mirvetuximab soravtansine systemic
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information

Frequently asked questions

View more FAQ

Learn more about Ovarian Cancer

Care guides

Symptoms and treatments

Medicine.com guides (external)

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.